Common Sense in Oncology

+ Add to Email Alerts
- At ASCO, the Cancer Community Hyped the Wrong Trial
- What's Wrong With Cancer Clinical Trials? Look at Olaparib
1
- The CodeBreaK Trial: We Broke the Code in More Ways Than One
6
- Why Is the FDA Granting Regular Approvals Prematurely?
- A Controversial Trial: Exposing Misunderstandings of NordICC
7
- The Great Irony of Modern Oncology: Immunotherapy's Imprecision
14
- Attending ASCO in Person This Year? Remember These 14 Tips
- Cancer Groundshot: From Blog Post to ASCO Session
- Racism in Medicine: But Where Do You Really Come From?
35
- The FDA Should Listen to Its Own Evidence on Surrogate Markers
- Early Cancer Drug Results: Are We Celebrating Too Soon?
2
- FDA's Accelerated Approval Pathway Is Broken
5
- How Do You Tell Someone Over the Phone That They're Dying?
15
- Discussing Patients' Private Lives for Better Cancer Care
1
- Where Is the Evidence for Supportive Oncology?
- Virtual ASCO Levels the Playing Field for Oncologists Everywhere
- Lessons on COVID-19 From Low-Income Countries
5
- Oncologists Are 'Sacrificing Common Sense' in Pursuit of Innovation
6
- What Do You Do When Your Patient Starts to Cry?
101
- Your First ASCO: Remember, the Goal Is to Feel Inspired